Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 936 entries
Sorted by: Best Match Show Resources per page
[Immunosuppressive agents].

Recenti progressi in medicina

Mowbray JF.
PMID: 5537180
Recenti Prog Med. 1970 Apr;48(4):360-72.

No abstract available.

Cite
Mowbray JF. Gli agenti immunosoppressori. [Immunosuppressive agents]. Recenti Prog Med. 1970;48(4):360-72
Mowbray, J. F. (1970). Gli agenti immunosoppressori. [Immunosuppressive agents]. Recenti progressi in medicina, 48(4), 360-72.
Mowbray, J F. "Gli agenti immunosoppressori." [Immunosuppressive agents]. Recenti progressi in medicina vol. 48,4 (1970): 360-72.
Mowbray JF. Gli agenti immunosoppressori. [Immunosuppressive agents]. Recenti Prog Med. 1970 Apr;48(4):360-72. Italian. PMID: 5537180.
Copy Download .nbib Format: NLM
Importance of Accurate Diagnosis in Pyoderma Gangrenosum.

Archives of craniofacial surgery

Kim YS, Kim HK, Han YS.
PMID: 28913208
Arch Craniofac Surg. 2014 Dec;15(3):138-141. doi: 10.7181/acfs.2014.15.3.138. Epub 2014 Dec 23.

Pyoderma gangrenosum is a rare inflammatory reactive dermatosis marked by painful cutaneous ulcers. Diagnosis of pyoderma gangrenosum is usually made based on past medical history and after the exclusion of other possible diseases based on the clinical manifestations of...

Cite
Kim YS, Kim HK, Han YS. Importance of Accurate Diagnosis in Pyoderma Gangrenosum. Arch Craniofac Surg. 2014;15(3):138-141doi: 10.7181/acfs.2014.15.3.138.
Kim, Y. S., Kim, H. K., & Han, Y. S. (2014). Importance of Accurate Diagnosis in Pyoderma Gangrenosum. Archives of craniofacial surgery, 15(3), 138-141. https://doi.org/10.7181/acfs.2014.15.3.138
Kim, Yoon Soo, et al. "Importance of Accurate Diagnosis in Pyoderma Gangrenosum." Archives of craniofacial surgery vol. 15,3 (2014): 138-141. doi: https://doi.org/10.7181/acfs.2014.15.3.138
Kim YS, Kim HK, Han YS. Importance of Accurate Diagnosis in Pyoderma Gangrenosum. Arch Craniofac Surg. 2014 Dec;15(3):138-141. doi: 10.7181/acfs.2014.15.3.138. Epub 2014 Dec 23. PMID: 28913208; PMCID: PMC5556732.
Copy Download .nbib Format: NLM
Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity.

Journal of transplantation

Cosner D, Zeng X, Zhang PL.
PMID: 26199736
J Transplant. 2015;2015:142521. doi: 10.1155/2015/142521. Epub 2015 Jun 24.

Tacrolimus (FK506) is one of the principal immunosuppressive agents used after solid organ transplantations to prevent allograft rejection. Chronic renal injury induced by tacrolimus is characterized by linear fibrosis in the medullary rays; however, the early morphologic findings of...

Cite
Cosner D, Zeng X, Zhang PL. Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity. J Transplant. 2015;2015:142521doi: 10.1155/2015/142521.
Cosner, D., Zeng, X., & Zhang, P. L. (2015). Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity. Journal of transplantation, 2015142521. https://doi.org/10.1155/2015/142521
Cosner, Diane, et al. "Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity." Journal of transplantation vol. 2015 (2015): 142521. doi: https://doi.org/10.1155/2015/142521
Cosner D, Zeng X, Zhang PL. Proximal Tubular Injury in Medullary Rays Is an Early Sign of Acute Tacrolimus Nephrotoxicity. J Transplant. 2015;2015:142521. doi: 10.1155/2015/142521. Epub 2015 Jun 24. PMID: 26199736; PMCID: PMC4495174.
Copy Download .nbib Format: NLM
Genes and podocytes - new insights into mechanisms of podocytopathy.

Frontiers in endocrinology

Bierzynska A, Soderquest K, Koziell A.
PMID: 25667580
Front Endocrinol (Lausanne). 2015 Jan 23;5:226. doi: 10.3389/fendo.2014.00226. eCollection 2014.

After decades of primarily morphological study, positional cloning of the NPHS1 gene was the landmark event that established aberrant podocyte genetics as a pivotal cause of malfunction of the glomerular filter. This ended any uncertainty whether genetic mutation plays...

Cite
Bierzynska A, Soderquest K, Koziell A. Genes and podocytes - new insights into mechanisms of podocytopathy. Front Endocrinol (Lausanne). 2015;5:226doi: 10.3389/fendo.2014.00226.
Bierzynska, A., Soderquest, K., & Koziell, A. (2014). Genes and podocytes - new insights into mechanisms of podocytopathy. Frontiers in endocrinology, 5226. https://doi.org/10.3389/fendo.2014.00226
Bierzynska, Agnieszka, et al. "Genes and podocytes - new insights into mechanisms of podocytopathy." Frontiers in endocrinology vol. 5 (2014): 226. doi: https://doi.org/10.3389/fendo.2014.00226
Bierzynska A, Soderquest K, Koziell A. Genes and podocytes - new insights into mechanisms of podocytopathy. Front Endocrinol (Lausanne). 2015 Jan 23;5:226. doi: 10.3389/fendo.2014.00226. eCollection 2014. PMID: 25667580; PMCID: PMC4304234.
Copy Download .nbib Format: NLM
Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness.

Therapeutic advances in musculoskeletal disease

Guerreiro Castro S, Isenberg DA.
PMID: 28344669
Ther Adv Musculoskelet Dis. 2017 Mar;9(3):75-85. doi: 10.1177/1759720X17690474. Epub 2017 Mar 01.

Systemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease with multiple presentations, whose management presents many challenges. Many disease modifying or immunosuppressive drugs have been used with limited success, especially in patients with more severe disease activity. Belimumab...

Cite
Guerreiro Castro S, Isenberg DA. Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness. Ther Adv Musculoskelet Dis. 2017;9(3):75-85doi: 10.1177/1759720X17690474.
Guerreiro Castro, S., & Isenberg, D. A. (2017). Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness. Therapeutic advances in musculoskeletal disease, 9(3), 75-85. https://doi.org/10.1177/1759720X17690474
Guerreiro Castro, Sara, and Isenberg, David A. "Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness." Therapeutic advances in musculoskeletal disease vol. 9,3 (2017): 75-85. doi: https://doi.org/10.1177/1759720X17690474
Guerreiro Castro S, Isenberg DA. Belimumab in systemic lupus erythematosus (SLE): evidence-to-date and clinical usefulness. Ther Adv Musculoskelet Dis. 2017 Mar;9(3):75-85. doi: 10.1177/1759720X17690474. Epub 2017 Mar 01. PMID: 28344669; PMCID: PMC5349337.
Copy Download .nbib Format: NLM
Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients.

Journal of clinical medicine

Chockalingam R, Downing C, Tyring SK.
PMID: 26239556
J Clin Med. 2015 Jun 03;4(6):1229-39. doi: 10.3390/jcm4061229.

Non-melanoma skin cancers represent a major cause of morbidity after organ transplantation. Squamous cell carcinomas (SCC) are the most common cutaneous malignancies seen in this population, with a 65-100 fold greater incidence in organ transplant recipients compared to the...

Cite
Chockalingam R, Downing C, Tyring SK. Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients. J Clin Med. 2015;4(6):1229-39doi: 10.3390/jcm4061229.
Chockalingam, R., Downing, C., & Tyring, S. K. (2015). Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients. Journal of clinical medicine, 4(6), 1229-39. https://doi.org/10.3390/jcm4061229
Chockalingam, Ramya, et al. "Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients." Journal of clinical medicine vol. 4,6 (2015): 1229-39. doi: https://doi.org/10.3390/jcm4061229
Chockalingam R, Downing C, Tyring SK. Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients. J Clin Med. 2015 Jun 03;4(6):1229-39. doi: 10.3390/jcm4061229. PMID: 26239556; PMCID: PMC4484997.
Copy Download .nbib Format: NLM
Clinical Study of Porokeratosis Associated with Immunosuppressive Therapy in Renal Transplant Recipients.

Annals of dermatology

Han YW, Kim YJ, Kim HO, Park YM.
PMID: 27303185
Ann Dermatol. 2008 Dec;20(4):167-71. doi: 10.5021/ad.2008.20.4.167. Epub 2008 Dec 31.

BACKGROUND: The etiology of porokeratosis (PK) remains unknown, but immunosuppression is known to be a factor in the pathogenesis of PK and it may also exacerbate PK.OBJECTIVE: The aim of this study was to examine the clinical characteristics of...

Cite
Han YW, Kim YJ, Kim HO, et al. Clinical Study of Porokeratosis Associated with Immunosuppressive Therapy in Renal Transplant Recipients. Ann Dermatol. 2008;20(4):167-71doi: 10.5021/ad.2008.20.4.167.
Han, Y. W., Kim, Y. J., Kim, H. O., & Park, Y. M. (2008). Clinical Study of Porokeratosis Associated with Immunosuppressive Therapy in Renal Transplant Recipients. Annals of dermatology, 20(4), 167-71. https://doi.org/10.5021/ad.2008.20.4.167
Han, Ye Won, et al. "Clinical Study of Porokeratosis Associated with Immunosuppressive Therapy in Renal Transplant Recipients." Annals of dermatology vol. 20,4 (2008): 167-71. doi: https://doi.org/10.5021/ad.2008.20.4.167
Han YW, Kim YJ, Kim HO, Park YM. Clinical Study of Porokeratosis Associated with Immunosuppressive Therapy in Renal Transplant Recipients. Ann Dermatol. 2008 Dec;20(4):167-71. doi: 10.5021/ad.2008.20.4.167. Epub 2008 Dec 31. PMID: 27303185; PMCID: PMC4903972.
Copy Download .nbib Format: NLM
An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.

Pulmonary circulation

Mehta MV, Manson DK, Horn EM, Haythe J.
PMID: 27162622
Pulm Circ. 2016 Mar;6(1):136-42. doi: 10.1086/685112.

Pulmonary arterial hypertension (PAH) is a known complication of rheumatologic diseases, but it is only rarely associated with adult-onset Still's disease (AOSD). We describe the case of a 30-year-old woman who presented in a pulmonary hypertension crisis and was...

Cite
Mehta MV, Manson DK, Horn EM, et al. An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature. Pulm Circ. 2016;6(1):136-42doi: 10.1086/685112.
Mehta, M. V., Manson, D. K., Horn, E. M., & Haythe, J. (2016). An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature. Pulmonary circulation, 6(1), 136-42. https://doi.org/10.1086/685112
Mehta, Mili V, et al. "An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature." Pulmonary circulation vol. 6,1 (2016): 136-42. doi: https://doi.org/10.1086/685112
Mehta MV, Manson DK, Horn EM, Haythe J. An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature. Pulm Circ. 2016 Mar;6(1):136-42. doi: 10.1086/685112. PMID: 27162622; PMCID: PMC4860549.
Copy Download .nbib Format: NLM
Nonimmunologic targets of immunosuppressive agents in podocytes.

Kidney research and clinical practice

Yoo TH, Fornoni A.
PMID: 26484025
Kidney Res Clin Pract. 2015 Jun;34(2):69-75. doi: 10.1016/j.krcp.2015.03.003. Epub 2015 Apr 09.

Proteinuria is a characteristic finding in glomerular diseases and is closely associated with renal outcomes. In addition, therapeutic interventions that reduce proteinuria improve renal prognosis. Accumulating evidence has demonstrated that podocytes act as key modulators of glomerular injury and...

Cite
Yoo TH, Fornoni A. Nonimmunologic targets of immunosuppressive agents in podocytes. Kidney Res Clin Pract. 2015;34(2):69-75doi: 10.1016/j.krcp.2015.03.003.
Yoo, T. H., & Fornoni, A. (2015). Nonimmunologic targets of immunosuppressive agents in podocytes. Kidney research and clinical practice, 34(2), 69-75. https://doi.org/10.1016/j.krcp.2015.03.003
Yoo, Tae-Hyun, and Fornoni, Alessia. "Nonimmunologic targets of immunosuppressive agents in podocytes." Kidney research and clinical practice vol. 34,2 (2015): 69-75. doi: https://doi.org/10.1016/j.krcp.2015.03.003
Yoo TH, Fornoni A. Nonimmunologic targets of immunosuppressive agents in podocytes. Kidney Res Clin Pract. 2015 Jun;34(2):69-75. doi: 10.1016/j.krcp.2015.03.003. Epub 2015 Apr 09. PMID: 26484025; PMCID: PMC4570600.
Copy Download .nbib Format: NLM
Entero-vesical fistulas in CROHN'S disease: A case series report and review of the literature.

International journal of surgery case reports

Vagianos C, Malgarinos G, Spyropoulos C, Triantafillidis JK.
PMID: 29546021
Int J Surg Case Rep. 2017 Nov 24;41:477-480. doi: 10.1016/j.ijscr.2017.11.035. eCollection 2017.

BACKGROUND: Entero-vesical fistula (EVF) is an abnormal link between the enteric lumen and the urinary bladder. Crohn's disease (CD) represents, nowadays, the most common cause in the formation of this fistula.MATERIALS AND METHODS: The aim of this study was...

Cite
Vagianos C, Malgarinos G, Spyropoulos C, et al. Entero-vesical fistulas in CROHN'S disease: A case series report and review of the literature. Int J Surg Case Rep. 2017;41:477-480doi: 10.1016/j.ijscr.2017.11.035.
Vagianos, C., Malgarinos, G., Spyropoulos, C., & Triantafillidis, J. K. (2017). Entero-vesical fistulas in CROHN'S disease: A case series report and review of the literature. International journal of surgery case reports, 41477-480. https://doi.org/10.1016/j.ijscr.2017.11.035
Vagianos, Costantine, et al. "Entero-vesical fistulas in CROHN'S disease: A case series report and review of the literature." International journal of surgery case reports vol. 41 (2017): 477-480. doi: https://doi.org/10.1016/j.ijscr.2017.11.035
Vagianos C, Malgarinos G, Spyropoulos C, Triantafillidis JK. Entero-vesical fistulas in CROHN'S disease: A case series report and review of the literature. Int J Surg Case Rep. 2017 Nov 24;41:477-480. doi: 10.1016/j.ijscr.2017.11.035. eCollection 2017. PMID: 29546021; PMCID: PMC5705824.
Copy Download .nbib Format: NLM
Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus.

Journal of clinical and experimental dentistry

Goel S, Marwah A, Kaushik S, Garg VK, Gupta S.
PMID: 26535093
J Clin Exp Dent. 2015 Oct 01;7(4):e477-82. doi: 10.4317/jced.52376. eCollection 2015 Oct.

BACKGROUND: Oral lichen planus (OLP) is a T cell mediated immune response. T cells locally present in the involved tissues release cytokines like interleukin-6 (IL-6), which contributes to pathogenesis of OLP. Also IL-6 has been associated with multidrug resistance...

Cite
Goel S, Marwah A, Kaushik S, et al. Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus. J Clin Exp Dent. 2015;7(4):e477-82doi: 10.4317/jced.52376.
Goel, S., Marwah, A., Kaushik, S., Garg, V. K., & Gupta, S. (2015). Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus. Journal of clinical and experimental dentistry, 7(4), e477-82. https://doi.org/10.4317/jced.52376
Goel, Sinny, et al. "Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus." Journal of clinical and experimental dentistry vol. 7,4 (2015): e477-82. doi: https://doi.org/10.4317/jced.52376
Goel S, Marwah A, Kaushik S, Garg VK, Gupta S. Role of serum interleukin-6 in deciding therapy for multidrug resistant oral lichen planus. J Clin Exp Dent. 2015 Oct 01;7(4):e477-82. doi: 10.4317/jced.52376. eCollection 2015 Oct. PMID: 26535093; PMCID: PMC4628801.
Copy Download .nbib Format: NLM
Granulomatosis with polyangiitis presenting as a choroidal tumor.

Case reports in rheumatology

Masuda T, Izumi Y, Takeshita H, Kawahara C, Tsuji Y, Kurohama H, Iwanaga N, Inamoto M, Kase K, Ito M, Kawakami A, Migita K.
PMID: 25949841
Case Rep Rheumatol. 2015;2015:271823. doi: 10.1155/2015/271823. Epub 2015 Apr 08.

Granulomatosis with polyangiitis (GPA) sometimes involves the eye orbit; however, choroidal involvements in GPA had been rarely reported. We report a rare case presenting with a choroidal mass in an 83-year-old Japanese woman who presented with left eye pain....

Cite
Masuda T, Izumi Y, Takeshita H, et al. Granulomatosis with polyangiitis presenting as a choroidal tumor. Case Rep Rheumatol. 2015;2015:271823doi: 10.1155/2015/271823.
Masuda, T., Izumi, Y., Takeshita, H., Kawahara, C., Tsuji, Y., Kurohama, H., Iwanaga, N., Inamoto, M., Kase, K., Ito, M., Kawakami, A., & Migita, K. (2015). Granulomatosis with polyangiitis presenting as a choroidal tumor. Case reports in rheumatology, 2015271823. https://doi.org/10.1155/2015/271823
Masuda, Taro, et al. "Granulomatosis with polyangiitis presenting as a choroidal tumor." Case reports in rheumatology vol. 2015 (2015): 271823. doi: https://doi.org/10.1155/2015/271823
Masuda T, Izumi Y, Takeshita H, Kawahara C, Tsuji Y, Kurohama H, Iwanaga N, Inamoto M, Kase K, Ito M, Kawakami A, Migita K. Granulomatosis with polyangiitis presenting as a choroidal tumor. Case Rep Rheumatol. 2015;2015:271823. doi: 10.1155/2015/271823. Epub 2015 Apr 08. PMID: 25949841; PMCID: PMC4407635.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 936 entries